New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
Move aligns global biologics identity under the Biocon Biologics brand
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees
Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
Subscribe To Our Newsletter & Stay Updated
